Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06752915

The Effect of Acupressure on Dyspnea and Anxiety Levels

The aim of this study is to determine the effect of acupressure applied to individuals with COPD on dyspnea and anxiety. It is important for the transfer of nonpharmacological methods to clinical applications.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

About this study

The pathophysiological changes that occur in the airways and alveoli in chronic obstructive pulmonary disease can cause many symptoms such as dyspnea, cough and sputum, which restrict the daily lives of individuals. Dyspnea and anxiety are at the top of the list among these symptoms, which affect individuals in many ways and limit them in many areas. While physiological, psychological and sociological factors cause dyspnea, the anxiety that develops in patients along with dyspnea also accompanies the symptoms. These symptoms seen in individuals with COPD not only negatively affect the quality of life of individuals, but also bring about psychological, cognitive, economic and social problems. Therefore, reducing anxiety and dyspnea in patients with COPD is of great importance in controlling the symptoms. Recently, acupressure has been frequently preferred among non-pharmacological methods in symptom control. As a result of studies conducted with different patient groups in the literature, it has been stated that acupressure reduces dyspnea and anxiety levels. In this study, five tools will be used: Patient Identification Form, Modified Borg Dyspnea Scale (MBS), Medical Research Council (MRC) Dyspnea Scale, Beck Anxiety Scale (BAÖ) and Patient Follow-up Schedule. Individuals will be applied acupressure once a day for two minutes at LI4, HT7, LU1, ST36 points, for a total of 20 sessions. It is of great importance for nurses to follow current care methods, include them in nursing care and improve themselves in this regard. No current study has been found in the literature investigating the effect of acupressure applied to individuals with COPD on dyspnea and anxiety. The purpose of this study is to determine the effect of acupressure applied to individuals with COPD on dyspnea and anxiety.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients who are literate,

Have moderate and severe stage COPD according to GOLD criteria,

Score 8 and above on the Beck Anxiety Inventory,

Patients who volunteer to participate in the study will be included in the study.

Exclusion criteria

  • Patients using psychiatric medication (anxiolytic, antidepressant), Those with serious pulmonary, cardiological or malignant diseases, Those with vision and hearing problems, Those with communication problems, Those with nerve, soft tissue and vascular diseases in the areas where acupressure will be applied, Those with infections and surgical operations in the areas where acupressure will be applied, Patients in the exacerbation period were not included in the study.

Treatment and study plan

acupressure application

Behavioral

Acupressure massage will be applied to LI4, HT7, LU1 and ST 36 acupuncture points for 2 minutes.

Primary outcomes

  1. Effect of acupressure on dyspnea and anxiety in individuals with COPD

    Time frame: through study completion, an average of 1 year

    The Modified Borg Dyspnea Scale (MBS) was developed in 1982 by Gunnar Borg to define the intensity of physical activity. The original Borg scale is scored between 6-20. In 1986, the "American College of Sports Medicine" revised the scale by scoring between 0-10. Although the Modified Borg Scale is frequently used today to define the severity of exertional dyspnea, it is also a scale that can be used to evaluate the severity of resting dyspnea. The fact that there are various definitions in the Modified Borg Scale (MBS) makes it easier for patients to apply.

  2. Effect of acupressure on dyspnea and anxiety in individuals with COPD

    Time frame: through study completion, an average of 1 year

    Medical Research Council Dyspnea Scale (MRC) The Medical Research Council (MRC) Dyspnea Scale was first used by Fletcher in 1952 to compare the severity of dyspnea during activity in people with and without lung disease. Later, the British Medical Research Council (MRC) introduced this scale in a more developed form to monitor the natural course of the disease. The dyspnea scale was created based on various physical activities that cause dyspnea. It consists of a total of 5 items and is a 1-5 point scale. The patient reads the scale options and selects the most appropriate degree that describes respiratory distress. In the MRC dyspnea scale, 1 describes the best dyspnea and 5 describes the worst. High scores on the scale indicate that the severity of shortness of breath is high.

  3. Effect of acupressure on dyspnea and anxiety in individuals with COPD

    Time frame: through study completion, an average of 1 year

    Beck Anxiety Inventory The Beck Anxiety Inventory is a three-point Likert-type assessment scale consisting of 21 items that measures the frequency of anxiety symptoms experienced by an individual (0=none, 1=mild, 2=moderate, 3=severe). The highest score that can be obtained from the scale is 63. The high total score indicates the severity of anxiety. A score between 0-7 indicates "minimal anxiety", 8-15 indicates "mild anxiety", 16-25 indicates "moderate anxiety", and 26-63 indicates "severe anxiety". The scale was developed by Beck and his colleagues in 1988 and its validity and reliability in Turkish were performed by Ulusoy, Şahin, and Erkmen in 1996, and the Cronbach's α value was reported to be 0.93.

  4. Effect of acupressure on dyspnea and anxiety in individuals with COPDThe schedule was prepared for the intervention group and will be used throughout the intervention.

    Time frame: through study completion, an average of 1 year

    Patient Follow-up Schedule Patients in the intervention group were followed up by phone calls every week to ensure regular and continuous acupressure application. The patient follow-up schedule was created by the researcher to record any problems with acupressure application and to provide the necessary information.

  5. KOAH'lı bireylerde uygulanan akupresürün dispne ve anksiyete üzerine etkisi

    Time frame: through study completion, an average of 1 year

    The Modified Borg Dyspnea Scale (MBS) was developed in 1982 by Gunnar Borg to define the intensity of physical activity. The original Borg scale is scored between 6-20. In 1986, the "American College of Sports Medicine" revised the scale by scoring between 0-10. Although the Modified Borg Scale is frequently used today to define the severity of exertional dyspnea, it is also a scale that can be used to evaluate the severity of resting dyspnea. The fact that there are various definitions in the Modified Borg Scale (MBS) makes it easier for patients to apply.

Sponsors and collaborators

Lead sponsor

ÇİĞDEM ERGİN

Other

Registry information

Official study title

The Aim of This Study is to Determine the Effect of Acupressure Applied to Individuals with COPD on Dyspnea and Anxiety: It is Important for the Transfer of Nonpharmacological Methods to Clinical Applications

Acronym: nursing

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Dec 31, 2024
Registry last updated
Dec 31, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.